Hips Don’t Lie: J&J Faces Compensation Maelstrom In India Over Faulty ASR Implants
Executive Summary
Johnson & Johnson is caught in the eye of a storm in India, after an expert panel recommended compensation for patients affected by its 'faulty' ASR hip implants. A stinging report by the panel raises several questions around J&J’s alleged “lack of seriousness” in addressing the issue - charges that the company denies - though it remains to be seen how the Indian government ensures that Indian patients get a fair deal.
You may also be interested in...
The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead
Legal experts discuss the intricacies around pharma’s demand for indemnity, a key sticking point for supplies of COVID-19 vaccines from Pfizer and Moderna, and the path forward for countries like India.
The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead
Legal experts discuss the intricacies around pharma’s demand for indemnity, a key sticking point for supplies of COVID-19 vaccines from Pfizer and Moderna, and the path forward for countries like India.
The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead
Legal experts discuss the intricacies around pharma’s demand for indemnity, a key sticking point for supplies of COVID-19 vaccines from Pfizer and Moderna, and the path forward for countries like India.